论文部分内容阅读
总结我院自 1995年以来 ,可列入疗效评定的用去甲氧柔红霉素 (idarubicin,Idr)方案诱导治疗的难治性急性白血病(AL ) 19例的临床疗效及其影响因素。结果如下。1 临床资料病例 本文 19例难治性 AL 病例均按德国 AML CG标准及第六届全国白血病会议制定的诊断标准。 19例中难治
To summarize the clinical efficacy and influencing factors of refractory acute leukemia (AL) induced by idarubicin (Idr) regimen in 19 patients evaluated in our hospital since 1995. The result is as follows. 1 clinical data cases 19 cases of refractory AL cases in this article are based on the German AML CG standard and the sixth national leukemia meeting established diagnostic criteria. Difficult to cure in 19 cases